Topic: Immunometabolism

The congress connects experimental and clinical pharmacology, from identifying therapeutic targets and testing mechanisms in preclinical models to clinical trials, access to treatment and evidence from routine care. Its programme examines synaptic and cellular communication in neurodegeneration, immunometabolism, inflammation, oncology, precision medicine and sex-aware experimental design. Sessions also address drug development, regulatory decisions, artificial intelligence and the sustainability of pharmacological research. Plenary lectures connect unmet needs in oncology to improved care and

The society’s 54th annual scientific meeting presents fundamental, translational and clinical immunology from Australia, New Zealand and the wider research community. Themes include infection, inflammation, autoimmunity, tumour immunology, immunometabolism, antigen presentation, B and T cells, mucosal and innate immunity, transplantation, vaccines and immunotherapies. The programme combines plenary lectures, symposia, special-interest-group workshops, a new-investigator session and poster presentations. The meeting takes place at QT Canberra from 30 November to 4 December. Paid registration of